Association between allelic variants in cytokine genes and preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 1, 2005, Pages 209-215

  Haggerty, Catherine L ^a,b   Ferrell, Robert E ^a   Hubel, Carl A ^b   Markovic, Nina ^a,b   Harger, Gail ^a   Ness, Roberta B ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cytokine; Genetic; Inflammation; Preeclampsia; Pregnancy

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; CASE-CONTROL STUDIES; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; INTERLEUKIN-1; LINKAGE DISEQUILIBRIUM; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VARIATION (GENETICS);

EID: 22244484095     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.11.008     Document Type: Article

References (53)

1. K.Y. Lain, and J.M. Roberts Contemporary concepts of the pathogenesis and management of preeclampsia JAMA 287 2002 3183 3186
2. R.E. Leach, R. Romero, Y.M. Kim, T. Chaiworapongsa, B. Kilburn, and S.K. Das Pre-eclampsia and expression of heparin-binding EGF-like growth factor Lancet 360 2002 1215 1219
3. A.M. Kaunitz, J.M. Hughes, D.A. Grimes, J.C. Smith, and R.W. Rochat Causes of maternal mortality in the United States, 1979-1986 Am J Obstet Gynecol 163 1990 460 465
4. C. Lenfant, R.W. Gifford Jr., and F. Zuspan National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy Am J Obstet Gynecol 163 suppl 1990 1689 1712
5. C.W. Redman, G.P. Sacks, and I.L. Sargent Preeclampsia: an excessive maternal inflammatory response to pregnancy Am J Obstet Gynecol 180 1999 499 506
6. D.F. Benyo, A. Smarason, C.W. Redman, C. Sims, and K.P. Conrad Expression of inflammatory cytokines in placentas from women with preeclampsia J Clin Endocrinol Metab 86 2001 2505 2512
7. S.E. Sanchez, C. Zhang, M.A. Williams, S. Ware-Jauregui, G. Larrabure, and V. Bazul Tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women J Reprod Immunol 47 2000 49 63
8. B.K. Rinehart, D.A. Terrone, S. Lagoo-Deenadayalan, W.H. Barber, E.A. Hale, and J.N. Martin Jr. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia Am J Obstet Gynecol 181 1999 915 920
9. W. Visser, I. Beckmann, M.A. Knook, and H.C. Wallenburg Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia Acta Obstet et Gynecol Scand 81 2002 713 719
10. E. Teran, C. Escudero, W. Moya, M. Flores, P. Vallance, and P. Lopez-Jaramillo Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia Int J Gynaecol Obstet 75 2001 243 249
11. F.V. Velzing-Aarts, F.A. Muskiet, F.P. van der Dijs, and A.J. Duits High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia: relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor Am J Reprod Immunol (Copenh) 48 2002 319 322
12. M.A. Williams, A. Farrand, R. Mittendorf, T.K. Sorensen, R.W. Zingheim, and G.C. O'Reilly Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia Am J Epidemiol 149 1999 323 329
13. S. Orange, J. Horvath, and A. Hennessy Preeclampsia is associated with a reduced interleukin-10 production from peripheral blood mononuclear cells Hypertens Pregnancy 22 2003 1 8
14. D. Darmochwal-Kolarz, J. Rolinski, B. Leszczynska-Goarzelak, and J. Oleszczuk The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients Am J Reprod Immunol (Copenh) 48 2002 381 386
15. A. Hennessy, H.L. Pilmore, L.A. Simmons, and D.M. Painter A deficiency of placental IL-10 in preeclampsia J Immunol 163 1999 3491 3495
16. D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, P.J. Sinnott, and I.V. Hutchinson An investigation of polymorphism in the interleukin-10 gene promoter Eur J Immunogen 24 1997 1 8
17. E. Crawley, R. Kay, J. Sillibourne, P. Patel, I. Hutchinson, and P. Woo Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 1999 1101 1108
18. M. Maurer, N. Kruse, R. Giess, K.V. Toyka, and P. Rieckmann Genetic variation at position -1082 of the interleukin 10 (IL10) promoter and the outcome of multiple sclerosis J Neuroimmunol 104 2000 98 100
19. M. Maurer, N. Kruse, R. Giess, K. Kyriallis, K.V. Toyka, and P. Rieckmann Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients J Neurol 246 1999 949 954
20. D.R. Huang, R. Pirskanen, G. Matell, and A.K. Lefvert Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis J Neuroimmunol 94 1999 165 171
21. A.G. Wilson, J.A. Symons, T.L. McDowell, H.O. McDevitt, and G.W. Duff Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Nat Acad Sci U S A 94 1997 3195 3199
22. G.M. Galbraith, R.B. Steed, J.J. Sanders, and J.P. Pandey Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype J Periodontol 69 1998 428 433
23. T. Pessi, J. Karjalainen, J. Hulkkonen, M.M. Nieminen, and M. Hurme A common IL-1 complex haplotype is associated with an increased risk of atopy J Med Gen 40 2003 e66
24. F. Pociot, J. Molvig, L. Wogensen, H. Worsaae, and J. Nerup A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro Eur J Clin Invest 22 1992 396 402
25. L.A. Hefler, C.B. Tempfer, and A.R. Gregg Polymorphisms within the interleukin-1 beta gene cluster and preeclampsia Obstet Gynecol 97 2001 664 668
26. A.M. Lachmeijer, M.P. Nosti-Escanilla, E.B. Bastiaans, G. Pals, L.A. Sandkuijl, and P.J. Kostense Linkage and association studies of IL1B and IL1RN gene polymorphisms in preeclampsia Hypertens Pregnancy 21 2002 23 38
27. D.S. Dizon-Townson, H. Major, and K. Ward A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia J Reprod Immunol 38 1998 55 61
28. G. Chen, R. Wilson, S.H. Wang, H.Z. Zheng, J.J. Walker, and J.H. McKillop Tumor necrosis factor alpha (TNF-alpha) gene polymorphism and expression in preeclampsia Clin Exp Immunol 104 1996 154 159
29. R.B. Ness Consequences for human reproduction of a robust inflammatory response Q Rev Biol 79 2004 383 393
30. M. Marzi, A. Vigano, D. Trabattoni, M.L. Villa, A. Salvaggio, and E. Clerici Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy Clin Exp Immunol 106 1996 127 133
31. G.P. Sacks, K. Studena, K. Sargent, and C.W. Redman Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis Am J Obstet Gynecol 179 1998 80 86
32. Y. Shi, J.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
33. P. Luppi, C. Haluszczak, D. Betters, C.A. Richard, M. Trucco, and J.A. DeLoia Monocytes are progressively activated in the circulation of pregnant women J Leukoc Biol 72 2002 874 884
34. G. Sacks, I. Sargent, and C. Redman An innate view of human pregnancy Immunol Today 20 1999 114 118
35. R.P. Heine, R.B. Ness, and J.M. Roberts Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia Obstet Gynecol 101 2003 221 226
36. L.I. Trogstad, A. Eskild, A.L. Bruu, S. Jeansson, and P.A. Jenum Is preeclampsia an infectious disease? Acta Obstet et Gynecol Scand 80 2001 1036 1038
37. L. Rustveld, R. Ness, J. Costantino, and J. Roberts Serological association between primary infections with herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), cytomegalovirus (CMV) and Epstein Barr virus (EBV) and the risk of preeclampsia [Abstract] Am J Epidemiol 157 2003 S74
38. H. Sartelet, C. Rogier, I. Milko-Sartelet, G. Angel, and G. Michel Malaria associated pre-eclampsia in Senegal Lancet 347 1996 1121
39. C.D. Hsu, and F.R. Witter Urogenital infection in preeclampsia Int J Gynaecol Obstet 49 1995 271 275
40. R. Mittendorf, K.Y. Lain, M.A. Williams, and C.K. Walker Preeclampsia: a nested, case-control study of risk factors and their interactions J Reprod Med 41 1996 491 496
41. J.A. Hill, L.D. Devoe, and C.I. Bryans Jr. Frequency of asymptomatic bacteriuria in preeclampsia Obstet Gynecol 67 1986 529 532
42. J.A. Herrera, G. Chaudhuri, and P. Lopez-Jaramillo Is infection a major risk factor for preeclampsia? Med Hypotheses 57 2001 393 397
43. M. Carreiras, S. Montagnani, and Z. Layrisse Preeclampsia: a multifactorial disease resulting from the interaction of the feto-maternal HLA genotype and HCMV infection Am J Reprod Immunol 48 2002 176 183
44. M. Knuist, G.J. Bonsel, H.A. Zondervan, and P.E. Treffers Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study Obstet Gynecol 92 1998 178
45. B.M. Sibai, M. Ewell, R.J. Levine, M.A. Klebanoff, J. Esterlitz, and P.M. Catalano Risk factors associated with preeclampsia in healthy nulliparous women: the Calcium for Preeclampsia Prevention (CPEP) Study group Am J Obstet Gynecol 177 1997 1010
46. R.A. Odegard, L.J. Vatten, S.T. Nilsen, K.A. Salvesen, and R. Austgulen Risk factors and clinical manifestations of pre-eclampsia BJOG 107 2000 1410 1416
47. F. Parazzini, R. Bortolus, L. Chatenoud, S. Restelli, E. Ricci, and L. Marozio Risk factors for pregnancy-induced hypertension in women at high risk for the condition Epidemiology 7 1996 306 308
48. J.L. Stone, C.J. Lockwood, G.S. Berkowitz, M. Alvarez, R. Lapinski, and R.L. Berkowitz Risk factors for severe preeclampsia Obstet Gynecol 83 1994 357 361
49. D. Mostello, T.K. Catlin, L. Roman, W.L. Holcomb Jr., and T. Leet Preeclampsia in the parous woman: Who is at risk? Am J Obstet Gynecol 187 2002 425 429
50. B. Eskenazi, L. Fenster, and S. Sidney A multivariate analysis of risk factors for preeclampsia JAMA 266 1991 237 241
51. J.M. Baeten, E.A. Bukusi, and M. Lambe Pregnancy complications and outcomes among overweight and obese nulliparous women Am J Publ Health 91 2001 436 440
52. M.P. Reilly, and D.J. Rader The metabolic syndrome: more than the sum of its parts? Circulation 108 2003 1546 1551
53. P.A. van den Velden, and P.H. Reitsma Amino acid dimorphism in IL1A is detectable by PCR amplification Hum Mol Genet 2 1993 1753